Running head: PROBLEM SOLUTION: GENEONE
Problem Solution: Gene One
Aaron Pough
University of Phoenix
Introduction
Gene One is a biotech company that started with a $2 million dollar start-up investment and has grown to a $400 million dollar company. On Wall Street biotech industry stock has rising to show interest in biotechnology. At Gene One, the CEO and the Board believe that in order to keep up with demand and realizing growth targets, Gene One need to go public within the next three years. The time seems right, but the Gene One will face numerous issues when trying to go public. Gene One will need new development, advertisement, join partnership and marketing to get IPO capital. If Gene One wants to go public they might want to look at benchmarking companies and how they prepare to go public and handling similar issues when going public. First Gene One must identify the major issues their going to face trying to go public, how they're going to response to the issues and the outcome they might have. Gene One is under a tremendous amount of pressure to push the company public. If the CEO Don Ruiz and the board want to push for an IPO, they might want to consider benchmarking after companies with similar issue in Gene One. Some of the Gene One issues are improving company brand image, improve marketing, restructuring to find new talent and developing a new business model to improve revenues.
Situation Analysis
There are many issues that arrived at Gene One when they wanted to jump from a private company to a public company. The CEO and the Board have devised a clear strategy with the help of key members in the investment community. As with all issues, there are many opportunities for Gene One and Senior L ...